Rating History for BioCryst Pharma (BCRX) by Evercore ISI
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/18/2026 | Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
17.00 (N/A) |
6.95 (8.48) |
22.01% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/18/2026 | Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
17.00 (N/A) |
6.95 (8.48) |
22.01% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||